Tumor-associated Macrophages
-
Obesity-cancer connection discovery suggests strategies for improving immunotherapy
The study reported in the journal Nature provides a mechanistic explanation for the “obesity paradox” — that obesity can contribute to cancer progression but also improve response to immunotherapy. Read MoreJun. 12, 2024
-
Harnessing a key growth pathway to reprogram tumor-associated macrophages
Researchers in the lab of Vivian Weiss, assistant professor of pathology, microbiology, and immunology, recently published a review article in Cancer Research that describes the role of the Wnt pathway in TAMs and tumor biology. Read MoreJan. 3, 2024
-
Nanoparticles boost anti-cancer immunity
The growth of epithelial ovarian cancer, one of the most lethal malignancies, is associated with the presence of tumor-associated macrophages (TAMs), white blood cells that can block the anti-cancer activity of the immune system and immunotherapy. Fortunately, TAMs can be “repolarized,” converted from immunosuppressive tumor-promoters to inflammatory tumor-fighters. Now,… Read MoreAug. 18, 2022